LAURENA NICOLO: Open Payments
NPI 1821578584 · METHUEN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$750 in 45 payments from 10 companies in 2025. Trend: 2023 $851 · 2024 $967 · 2025 $750
Food & beverage: $750
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $425 |
| Lilly USA, LLC | 3 | $81 |
| Abbott Laboratories | 4 | $73 |
| Novo Nordisk Inc | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Corcept Therapeutics | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, JARDIANCE, FREESTYLE LIBRE 3, QULIPTA, Ozempic, REXULTI, XIFAXAN.
Industry payments across MA — which companies pay providers there.
